Navigation Links
Cetaphil(R) Cleansers and Moisturizers Now the #1 Pediatrician Recommended Brand
Date:4/21/2009

Skin Care Brand Gains Another Top Recognition

FORT WORTH, Texas, April 21 /PRNewswire/ -- Galderma Laboratories' Cetaphil(R) cleansers and moisturizers, currently the #1 Dermatologist Recommended brand of cleansers and moisturizers, is now highly rated among pediatricians. Cetaphil(R) products are specially formulated to provide effective, gentle skin care to help your skin look and feel its best, and the brand has become the #1 recommended brand of cleansers and moisturizers among pediatricians. For caregivers who want to help their children's skin stay healthy and strong, pediatricians agree that Cetaphil(R) is the top choice for cleansers and moisturizers.

Cetaphil(R) features a full line of products including cleansers, moisturizers and cleansing bars. For healthy skin care, pediatricians agree that Cetaphil(R) is a brand you can count on.

In addition to a full line of products, the Cetaphil(R) brand offers the Cetaphil(R) Kids Care Corner, an online community and a monthly guide for parents, who are concerned about the skin care needs of their children. The Cetaphil(R) Kids Care Corner provides everything from pediatric-skin insights and solutions to the most pressing skin concerns, from diaper rash and eczema to acne, another reason why the brand has become a pediatrician favorite.

For more information about Cetaphil(R) products or to join the Cetaphil(R) Kids Care Corner or Skin Care Club,

visit www.cetaphil.com.

About Galderma

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully-integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company is committed to improving the health of skin with an extensive line of products across the world that treat a range of dermatological conditions With a research and development center in Sophia Antipolis, France, Galderma has one of the largest R&D facilities dedicated exclusively to dermatology. Leading worldwide dermatology brands include Differin(R), MetroGel(R) 1%/Rozex(R), Clobex(R), Tri-Luma(R), Loceryl(R), Vectical(TM) Ointment, Epiduo(TM) Gel and Cetaphil(R).

For more information on Galderma, visit www.galdermaUSA.com.

About Cetaphil

The Family of Cetaphil(R) Cleansers and Moisturizers is a line of dermatologist-recommended skin care products specially formulated for all skin types and conditions. Cetaphil(R) products are developed to provide effective, gentle skin care and include: Cetaphil(R) Gentle Skin Cleanser, Cetaphil(R) Daily Facial Cleanser, Cetaphil(R) Gentle Cleansing Bar, Cetaphil(R) Antibacterial Gentle Cleansing Bar, Cetaphil(R) Moisturizing Lotion, Cetaphil(R) Moisturizing Cream, Cetaphil(R) DailyAdvance(TM) Ultra Hydrating Lotion, Cetaphil(R) Daily Facial Moisturizer SPF 15, Cetaphil(R) Therapeutic Hand Cream, Cetaphil(R) UVA/UVB Defense SPF 50.

To learn more about Cetaphil(R) products and to join the Cetaphil(R) Skin Care Club visit www.cetaphil.com


'/>"/>
SOURCE Galderma Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Galderma Launches New Cetaphil(R) SPF 50 Product
2. Three Cetaphil(R) Products Awarded National Eczema Association Seal of Acceptance
3. November 2008 Mayo Clinic Health Letter Highlights Moisturizers, Potatoes and Varicose Veins
4. Parental surveys boost diagnosis abilities of pediatricians
5. Pediatricians Awarded for Innovative Approaches to Combat Childhood Obesity
6. Pediatricians Group Issues New Autism Guidelines
7. Pediatricians call for a cohesive definition of metabolic syndrome in children
8. Neonatologists and Pediatricians Highlight Progress and Barriers to Preemie Care
9. Neonatologists and pediatricians highlight progress and barriers to preemie care
10. American College of Pediatricians Questions Validity of Spanking Study
11. Parents follow pediatrician advice on administering MMR vaccinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's ... facets of clinical trial planning and management. Pharmica discussed the importance of effective ... addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: